No black box warning on record for Armodafinil

As of the latest FDA labeling reviewed, Armodafinil (ARMODAFINIL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Armodafinil medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Rash, including Stevens-Johnson Syndrome: discontinue armodafinil at the first sign of rash, unless the rash is clearly not drug-related. ( 5.1 ) DRESS/Multi-organ Hypersensitivity Reactions: if suspected, discontinue armodafinil. ( 5.2 ) Angioedema and Anaphylaxis Reactions: if suspected, discontinue armodafinil. ( 5.3 ) Persistent Sleepiness: assess patients fr

No black box warning on record for Armodafinil

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serious Rash, including Stevens-Johnson Syndrome: discontinue armodafinil at the first sign of rash, unless the rash is clearly not drug-related. ( 5.1 ) DRESS/Multi-organ Hypersensitivity Reactions: if suspected, discontinue armodafinil. ( 5.2 ) Angioedema and Anaphylaxis Reactions: if suspected, discontinue armodafinil. ( 5.3 ) Persistent Sleepiness: assess patients fr

Armodafinil Black Box Warning

No black box warning on record for Armodafinil

Other warnings & precautions

Armodafinil Black Box Warning

No black box warning on record for Armodafinil

Other warnings & precautions